Moving Biosimilars Forward in a Hesitant Market
Despite a growing number of biosimilar approvals, market uptake remains a challenge.
Fouling Mechanisms of Filters During the Harvest Development of Monoclonal Antibody Therapeutics with Intensified Upstream Processes—Part 2
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
Proprietary Cell-Line Development for High-Titer AAV Manufacturing
Proprietary cell lines offer opportunities for achieving high AAV titers.
The Making of mRNA
A tidal wave of questions floats the need for more upstream automation.
Automating the Future of Fill/Finish
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
Biologics Quality Control: The Growing Need for Accessible Proteomics
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
First in Line on Catalent’s Line
While Catalent’s acquisition is definitely about making drugs, it’s also very much about making money.
Ensuring Contractors Perform Good Distribution Practices
The license holder should negotiate, educate, contract, and then oversee the transportation contractor, says Siegfried Schmitt, vice president, Technical at Parexel.
